Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Journal of the Neurological Sciences
|
July 11, 2006
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms
L Elmer, S Schwid, S Eberly, et al.
Nucleic Acid Therapeutics
|
August 29, 2023
Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849 + 10 kb C- > T Cystic Fibrosis Patients
Efrat Ozeri-Galai, Lital Friedman, Ofra Barchad-Avitzur, et al.
Cell Stem Cell
|
January 16, 2013
Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen
Uri Ben-David, Qing-Fen Gan, Tamar Golan-Lev, et al.
EMBO Molecular Medicine
|
April 8, 2014
The unfolded protein response affects readthrough of premature termination codons
Yifat S Oren, Michelle L McClure, Steven M Rowe, et al.
Annals of the Rheumatic Diseases
|
November 6, 2007
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response
S Oren, M Mandelboim, Y Braun-Moscovici, et al.
Plos One
|
March 26, 2013
LRRC6 mutation causes primary ciliary dyskinesia with dynein arm defects
Amjad Horani, Thomas W Ferkol, David Shoseyov, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
January 1, 2022
Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation
Yifat S Oren, Ofra Avizur-Barchad, Efrat Ozeri-Galai, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 25, 2026
SPL84 and trikafta® exhibit comparable and additive effects in patient-derived HBE cells carrying the 3849+10kb C→T/F508del CFTR variants
Yi Cheng, Yifat S Oren, Jan Harrington, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 6, 2021
Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation
Yifat S Oren, Michal Irony-Tur Sinai, Anita Golec, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Journal of the Neurological Sciences
|
July 11, 2006
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms
L Elmer, S Schwid, S Eberly, et al.
Nucleic Acid Therapeutics
|
August 29, 2023
Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849 + 10 kb C- > T Cystic Fibrosis Patients
Efrat Ozeri-Galai, Lital Friedman, Ofra Barchad-Avitzur, et al.
Cell Stem Cell
|
January 16, 2013
Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen
Uri Ben-David, Qing-Fen Gan, Tamar Golan-Lev, et al.
EMBO Molecular Medicine
|
April 8, 2014
The unfolded protein response affects readthrough of premature termination codons
Yifat S Oren, Michelle L McClure, Steven M Rowe, et al.
Annals of the Rheumatic Diseases
|
November 6, 2007
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response
S Oren, M Mandelboim, Y Braun-Moscovici, et al.
Plos One
|
March 26, 2013
LRRC6 mutation causes primary ciliary dyskinesia with dynein arm defects
Amjad Horani, Thomas W Ferkol, David Shoseyov, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
January 1, 2022
Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation
Yifat S Oren, Ofra Avizur-Barchad, Efrat Ozeri-Galai, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 25, 2026
SPL84 and trikafta® exhibit comparable and additive effects in patient-derived HBE cells carrying the 3849+10kb C→T/F508del CFTR variants
Yi Cheng, Yifat S Oren, Jan Harrington, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 6, 2021
Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation
Yifat S Oren, Michal Irony-Tur Sinai, Anita Golec, et al.
Page
of 8